Tagged with Skincare,

Colombia Carlos and Esteban Arteaga, CEO and Line Manager at Medivelius, a company that distributes European dermocosmetic products of the highest quality in a price driven Colombian market, discuss how their loyalty to skin stores has engendered their success, while highlighting the importance of developing strong ties with dermatologists. Medivelius is…

Colombia David Torres, general manager of NAOS Colombia, one of the country’s most innovative firms, discusses the inherent challenges in the skincare industry and the specificities of the Colombian market, while highlighting the importance of institutional collaboration to raise skin-related issues and the affiliate’s priorities to further expand its footprint in…

Indonesia Holger Welters, President Director at Beiersdorf Indonesia, discusses the ambitious growth plan for emerging markets that is propelling the company to new heights and sheds light on the importance of bringing high quality skincare solutions to Indonesia through Nivea® and Hansaplast®. Mr. Welters, you have been President Director of Beiersdorf’s…

Taiwan Ken-Shwo Dai, president and CEO of Visgeneer, explains his biotech’s expertise in medtech, skincare, gene therapy and diagnostics, as well as his plans to take the company public. Can you introduce yourself and Visgeneer to our readers? What have been the main milestones for the company so far? “Visgeneer believes that…

Mexico In charge of transforming the Monterrey-based family business of dermatological distribution into a Mexican corporate success story, Carlos de Kruyff, shares some of his most pertinent insights on the industry. He speaks about the company’s history and innovative commercialization scheme, the transformative regulatory landscape today, as well as their role…

Switzerland Treating common skin, hair and scalp conditions with “close to nature” products, the 127-year-old family company Rausch has effective and high quality products, but is working to reposition the brand to engage younger customers. To begin, could you please introduce Rauch and the niche cosmetics segment in which you work?…

Switzerland In the marketing-driven dermocosmetics sector, the Swiss cosmetics association has recently achieved the passage of a strict new law limiting the usage of the “made in Switzerland” claim for cosmetics industry, and is making progress protecting the usage of this very valuable brand in markets around the world. What would…

Mexico Joel Osorio, CEO & Founder Alejandro De La Parra, Co-Founder & Chief Operating Officer Alexa Jeppi, Co-Founder, RegenerAge Beauty & Health Ira Pastor, Board Member             The CEO of RegenerAge, Dr. Joel Osorio, explains the transformative power of Bioquantine—a novel biological complex used in regenerative…

Switzerland LEO Pharma’s Country Lead for Switzerland, Patrick Brunner, discusses the skincare specialist’s most important products, the Swiss affiliate’s significance to the global group, and the exciting new partnership with AstraZeneca. LEO Pharma Switzerland was established back in 1991 meaning that, last year, you celebrated 25 years of in-country operations. Could…

Pharma The country manager of LEO Pharma Czech Republic and Slovakia explains how the recent acquisition of Astella’s dermatology portfolio will triple the revenue of the affiliate and how LEO always puts patients first Could you please introduce yourself and the cornerstones of your longstanding career in the pharmaceutical industry? The…

Pharma Eric Ducournau, CEO of Pierre Fabre Dermo-Cosmétique (PFDC), discusses the company’s revolutionary lines of dermatologically tested skincare products and their niche adapted internationalization strategy that is focused on providing the highest-quality skincare products for all consumer and patient needs. The Dermo-Cosmetics division of Pierre Fabre has represented about 55 percent…

Pharma Stéphane Thiroloix, CEO of the independent and family owned Mayoly Spindler, reveals how their vision is to become a reference company internationally in the field of gastroenterology and dermocosmetics; how already forty-five percent of their business is done overseas; and how on current projections, excluding external growth, they anticipate to…